The purpose of this study is to assess the safety and efficacy of umbilical cord blood mesenchymal stem cells with peripheral arterial disease.
The present study is designed to implant UCB-MSC in patients with CLI, which are resulted from peripheral arterial disease,such as thromboangiitis obliterans, atherosclerosis obliterans and diabetic foot, and to evaluate the safety and efficacy of the implantation procedure.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
28
To evaluate safety and tolerability related to the intramuscular injection of autologous Umbilical cord blood derived stem cells.
Amputation rate and mortality will be combined to report safty in %
Time frame: 6 months
To evaluate effectiveness related to the intramuscular injection of autologous Umbilical cord blood derived stem cells.
Rest pain, temperature of skin and cold feeling will be combined to report effectiveness in score.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.